









시장가
/
주식
/
nasdaq-neo
/

Neogenomics Inc

NEO

5.415USD

+0.255+4.94%

시장 운영 시간 （ET）시세는 15분 지연됩니다

696.81M시가총액

손실P/E TTM



Neogenomics Inc

5.415

+0.255+4.94%

개요 회사 금융

NeoGenomics, Inc. provides a range of oncology diagnostic testing and consultative services which includes technical laboratory services. The Company offers professional interpretation of laboratory test results by licensed physicians who specialize in pathology and oncology. Its segments include Clinical Services and Advanced Diagnostics. The Clinical Services segment consists of clinical cancer testing; interpretation and consultative services; molecular and NGS testing, and comprehensive technical and professional services offering. Its Clinical Services customers include community-based pathology and oncology practices, hospital pathology labs, reference labs, and academic centers. The Advanced Diagnostics segment consist of clinical trials and research, validation laboratory services, and informatics. Its Advanced Diagnostics customers include pharmaceutical companies to whom it provides testing and other services to support their research studies and clinical trials.

회사 정보

종목 코드 NEO

회사 이름Neogenomics Inc

상장일Dec 10, 2012

CEOMr. Antony P. Zook

직원 수2200

유형Ordinary Share

회계 연도 종료Dec 10

주소9490 Neogenomics Way

도시FORT MYERS

증권 거래소NASDAQ Capital Market Consolidated

국가United States of America

우편 번호33912

전화12397680600

웹사이트https://neogenomics.com/

종목 코드 NEO

상장일Dec 10, 2012

CEOMr. Antony P. Zook

회사 임원

이름

이름/직위

직위

주식 보유

변동

Mr. Jeffrey Scott (Jeff) Sherman

Chief Financial Officer

166.66K

+21.81%

Mr. Warren Stone

President, Chief Operating Officer

108.28K

+19.26%

Mr. Stephen Michael Kanovsky

Independent Director

52.34K

+30.57%

Dr. Neil Gunn

Independent Director

28.10K

+77.33%

Ms. Elizabeth Floegel

Independent Director

23.59K

+108.10%

Ms. Felicia Williams

Independent Director

7.16K

Ms. Marjorie C. Green

Independent Director

Mr. David B. Perez

Independent Director

Ms. Alicia Olivo

Executive Vice President, General Counsel & Business Development

Mr. Michael A. Kelly

Lead Independent Director

이름

이름/직위

직위

주식 보유

변동

Mr. Jeffrey Scott (Jeff) Sherman

Chief Financial Officer

166.66K

+21.81%

Mr. Warren Stone

President, Chief Operating Officer

108.28K

+19.26%

Mr. Stephen Michael Kanovsky

Independent Director

52.34K

+30.57%

Dr. Neil Gunn

Independent Director

28.10K

+77.33%

Ms. Elizabeth Floegel

Independent Director

23.59K

+108.10%

Ms. Felicia Williams

Independent Director

7.16K

수익 분석

통화: USD마지막 업데이트: Sun, Jul 6

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

사업별USD

이름

수익

비율

Clinical Services-Client direct billing

122.04M

72.63%

Clinical Services-Commercial Insurance

24.86M

14.79%

Clinical Services-Medicare and Medicaid

21.10M

12.56%

Clinical Services-Self-Pay

39.00K

0.02%

데이터 없음

사업별

지역별

사업별USD

이름

수익

비율

Clinical Services-Client direct billing

122.04M

72.63%

Clinical Services-Commercial Insurance

24.86M

14.79%

Clinical Services-Medicare and Medicaid

21.10M

12.56%

Clinical Services-Self-Pay

39.00K

0.02%

주식 보유 통계

마지막 업데이트: Wed, May 14

주주

주주 유형

주주

비율

BlackRock Institutional Trust Company, N.A.

14.16%

The Vanguard Group, Inc.

11.01%

First Light Asset Management, LLC

4.68%

Janus Henderson Investors

4.44%

State Street Global Advisors (US)

3.94%

Other

61.77%

주주

비율

BlackRock Institutional Trust Company, N.A.

14.16%

The Vanguard Group, Inc.

11.01%

First Light Asset Management, LLC

4.68%

Janus Henderson Investors

4.44%

State Street Global Advisors (US)

3.94%

Other

61.77%

주주 유형

주주

비율

Investment Advisor

50.11%

Investment Advisor/Hedge Fund

37.15%

Hedge Fund

7.37%

Research Firm

1.52%

Individual Investor

1.19%

Pension Fund

1.13%

Bank and Trust

0.58%

Sovereign Wealth Fund

0.39%

Insurance Company

0.04%

Other

0.51%

기관 주식 보유

마지막 업데이트: Tue, Jul 1

보고 기간

기관 수

보유 주식

비율

변동

2025Q2

569

127.92M

99.03%

-12.74M

2025Q1

596

131.44M

102.13%

-4.71M

2024Q4

585

127.59M

99.32%

-7.82M

2024Q3

589

129.38M

100.96%

-8.76M

2024Q2

597

131.21M

102.74%

-9.36M

2024Q1

633

132.83M

104.04%

-13.13M

2023Q4

672

130.90M

102.70%

-12.18M

2023Q3

691

124.98M

98.00%

-16.78M

2023Q2

691

121.76M

95.45%

-23.63M

2023Q1

704

120.14M

94.21%

-27.80M

주주 활동

이름

보유 주식

비율

변동

Chg %

날짜

BlackRock Institutional Trust Company, N.A.

18.29M

14.21%

-356.84K

-1.91%

Mar 31, 2025

The Vanguard Group, Inc.

14.23M

11.06%

+17.23K

+0.12%

Mar 31, 2025

First Light Asset Management, LLC

6.04M

4.7%

+2.88M

+90.77%

Mar 31, 2025

Janus Henderson Investors

5.74M

4.46%

-424.04K

-6.88%

Mar 31, 2025

State Street Global Advisors (US)

5.09M

3.95%

-109.12K

-2.10%

Mar 31, 2025

Greenhouse Funds LLLP

4.71M

3.66%

+6.43K

+0.14%

Mar 31, 2025

Macquarie Investment Management

4.68M

3.63%

+864.39K

+22.67%

Mar 31, 2025

Schroder Investment Management North America Inc.

4.31M

3.35%

+509.99K

+13.42%

Mar 31, 2025

Brown Advisory

3.87M

3.01%

-2.28M

-37.10%

Mar 31, 2025

Dimensional Fund Advisors, L.P.

3.85M

2.99%

+408.27K

+11.88%

Mar 31, 2025